Carbasalate calcium
Source: Wikipedia, the free encyclopedia.
Chemical compound
ECHA InfoCard 100.024.794 | |
Carbasalate calcium is an
References
Antiplatelet drugs |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
) | |||||||||||||||
Factor Xa inhibitors (with some II inhibition) |
| ||||||||||||||
Direct thrombin (IIa) inhibitors |
| ||||||||||||||
Other |
fibrinolytics
- r-tPA
- UPA
- Anistreplase
- Monteplase
- Streptokinase#
- Other serine endopeptidases: Ancrod‡
- Brinase
- Fibrinolysin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
profens ) |
|
n-arylanthranilic acids ( fenamates ) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |